Search
Search Results
- Author(s):
- Emond, Sarah K., author
Reed, Sarah Jane, author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, [2013]
- Subject(s):
- Outcome Assessment (Health Care) -- economics
Prostatic Neoplasms -- prevention & control
Prostatic Neoplasms -- therapy
Reimbursement Mechanisms -- economics
Comparative Effectiveness Research
Health Care Reform -- economics
Current Procedural Terminology
Pilot Projects
Program Evaluation
Quality Indicators, Health Care -- classification
Recurrence
Surveys and Questionnaires
Humans
United States
- Author(s):
- Pearson, Steven D., author
Ollendorf, Daniel A., author
Colby, Jennifer A., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, [2012]
- Subject(s):
- Alzheimer Disease -- diagnosis
Diagnostic Tests, Routine -- methods
Evidence-Based Practice
Insurance Coverage
Biomarkers
Biomedical Research -- methods
Clinical Protocols
Clinical Trials as Topic -- methods
Early Diagnosis
Insurance, Health
Neuropsychological Tests
Outcome Assessment (Health Care)
Patient Outcome Assessment
Policy Making
Practice Guidelines as Topic
Predictive Value of Tests
Prognosis
Randomized Controlled Trials as Topic
Reproducibility of Results
Translational Medical Research -- methods
Humans
United States
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, April 15, 2014
- Subject(s):
- Comparative Effectiveness Research
Hepatitis C, Chronic -- drug therapy
Heterocyclic Compounds, 3-Ring -- therapeutic use
Sulfonamides -- therapeutic use
Uridine Monophosphate -- analogs & derivatives
Uridine Monophosphate -- therapeutic use
Antiviral Agents -- economics
Antiviral Agents -- therapeutic use
Cost-Benefit Analysis
Drug Costs
Drug Therapy, Combination
Genotype
Hepatitis C -- economics
Hepatitis C -- genetics
Heterocyclic Compounds, 3-Ring -- adverse effects
Heterocyclic Compounds, 3-Ring -- economics
Insurance Coverage
Interferon-alpha -- therapeutic use
Oligopeptides -- therapeutic use
Polyethylene Glycols -- therapeutic use
Proline -- analogs & derivatives
Proline -- therapeutic use
Protease Inhibitors -- economics
Protease Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Ribavirin -- therapeutic use
Sulfonamides -- adverse effects
Technology Assessment, Biomedical
Treatment Outcome
Uridine Monophosphate -- adverse effects
Uridine Monophosphate -- economics
Value-Based Purchasing
Humans
United States
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Cunningham, Courtney, author
Pearson, Steven D., author
Kazi, Dhruv S., author
Coxson, Pamela G., author
Moran, Andrew E., author
Penko, Joanne, author
Guzman, David, author
Bibbins-Domingo, Kirsten, author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, November 24, 2015
- Subject(s):
- Anticholesteremic Agents -- therapeutic use
Azetidines -- therapeutic use
Enzyme Inhibitors -- therapeutic use
Hypercholesterolemia -- therapy
Hyperlipoproteinemia Type II -- prevention & control
Proprotein Convertases -- economics
Serine Endopeptidases -- economics
Cholesterol, LDL
Cost-Benefit Analysis
Decision Support Techniques
Drug Costs
Drug Resistance
Practice Guidelines as Topic
Randomized Controlled Trials as Topic
Technology Assessment, Biomedical
Treatment Outcome
Value-Based Purchasing
Humans
New England
United States
- Author(s):
- Ollendorf, Daniel A., author
Ollendorf, Daniel A., author
Tarlochan Sandhu, Alexander, author
Chapman, Rick, author
Heidenreich, Paul A., author
Russo, Elizabeth, author
Shore, Karen K., author
Synnott, Patricia, author
Travers, Karin, author
Weissberg, Jed, author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, December 1, 2015
- Subject(s):
- Angiotensin II Type 1 Receptor Blockers -- administration & dosage
Antihypertensive Agents -- administration & dosage
Blood Pressure Monitoring, Ambulatory -- instrumentation
Blood Pressure Monitoring, Ambulatory -- methods
Heart Failure -- diagnosis
Heart Failure -- drug therapy
Neprilysin -- administration & dosage
Tetrazoles -- administration & dosage
Valsartan -- administration & dosage
Angiotensin II Type 1 Receptor Blockers -- economics
Antihypertensive Agents -- economics
Cost-Benefit Analysis
Drug Combinations
Drug Costs
Neprilysin -- antagonists & inhibitors
Neprilysin -- economics
Outcome and Process Assessment (Health Care)
Tetrazoles -- economics
Valsartan -- economics
Humans
United States
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Reed, Sarah Jane, author
Shore, Karen K., author
Weissberg, Jed, author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, June 2, 2015
- Subject(s):
- Delivery of Health Care, Integrated -- methods
Delivery of Health Care, Integrated -- organization & administration
Mental Health Services -- organization & administration
Outcome Assessment (Health Care) -- organization & administration
Primary Health Care -- organization & administration
Technology Assessment, Biomedical
Anxiety Disorders -- therapy
Chronic Disease
Clinical Competence
Confidentiality
Depression -- therapy
Electronic Health Records
Health Manpower
Health Status
Information Services
Insurance Coverage
Insurance, Health
Medicaid
Medicare
Models, Organizational
Patient Satisfaction
Practice Guidelines as Topic
Quality of Life
Reimbursement Mechanisms
Substance-Related Disorders -- therapy
Humans
United States
- Author(s):
- Pearson, Steven D., author
Dreitlein, Bill, author
Henshall, Chris, author
- Publication:
- Boston, MA : Institute for Clinical and Economic Review, March 2016
- Subject(s):
- Drug Costs
Economics, Pharmaceutical
Insurance, Pharmaceutical Services -- economics
Prospective Payment System
Reimbursement Mechanisms -- economics
Cost Savings
Cost Sharing
Formularies
Medicaid -- economics
Medicare -- economics
Off-Label Use -- economics
Pilot Projects
Value-Based Purchasing
Humans
United States
- Author(s):
- Cunningham, Courtney, author
Trevers, Karin, author
Chapman, Rick, author
Loos, Anne, author
Lawler, Erin, author
Liu, Shanshan, author
Pearson, Steven D., author
Ollendorf, Daniel A., author
- Publication:
- Boston, MA : Institute for Clinical and Economic Review, April 27, 2016
- Subject(s):
- Ambulatory Care -- organization & administration
Comparative Effectiveness Research
Palliative Care -- organization & administration
Anxiety -- therapy
Caregivers
Clinical Trials as Topic
Cost Savings
Cost-Benefit Analysis
Depression -- therapy
Health Policy
Health Resources -- utilization
Health Services Accessibility
Healthcare Disparities
Insurance, Health, Reimbursement
Medicaid -- economics
Medicare -- economics
Outcome Assessment (Health Care)
Palliative Care -- manpower
Patient Education as Topic
Patient Satisfaction
Quality of Life
Research
Spirituality
Humans
United States
- Author(s):
- Pearson, Steven D., author
Banken, Reiner, author
Chapman, Rick, author
Russo, Elizabeth T., author
Loos, Anne M., author
Emond, Sarah K., author
Segel, Celia S., author
Ollendorf, Daniel A., author
Chhatwal, Jagpreet, author
Hur, Chin, author
Klebanoff, Matthew, author
Samur, Sumeyye K., author
- Publication:
- Boston, MA : Institute for Clinical and Economic Review, July 26, 2016
- Subject(s):
- Bile Acids and Salts -- agonists
Comparative Effectiveness Research
Fatty Liver -- drug therapy
Bile Acids and Salts -- adverse effects
Diabetes Mellitus, Type 2
Dyslipidemias
Liver Cirrhosis -- prevention & control
Quality of Life
Randomized Controlled Trials as Topic
Humans
United States
- Author(s):
- Pearson, Steven D., author
Banken, Reiner, author
Chapman, Rick, author
Emond, Sarah K., author
Loos, Anne M., author
Russo, Elizabeth T., author
Segel, Celia S., author
Ollendorf, Daniel A., author
Chhatwal, Jagpreet, author
Hur, Chin, author
Klebanoff, Matthew, author
Samur, Sumeyye, author
- Publication:
- Boston, MA : Institute for Clinical and Economic Review, March 2016
- Subject(s):
- Bile Acids and Salts -- agonists
Cholangitis -- drug therapy
Comparative Effectiveness Research
Value-Based Purchasing
Benchmarking
Bile Acids and Salts -- adverse effects
Bile Acids and Salts -- economics
Cost-Benefit Analysis
Liver Cirrhosis -- prevention & control
Liver Transplantation
Pruritus
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Campbell, Jonathan D., author
Chapman, Rick, author
Shore, Karen K., author
Weissberg, Jed, author
Whittington, Melanie, author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, March 14, 2016
- Subject(s):
- Adrenergic beta-2 Receptor Agonists -- economics
Adrenergic beta-2 Receptor Agonists -- therapeutic use
Anti-Asthmatic Agents -- administration & dosage
Anti-Asthmatic Agents -- economics
Antibodies, Monoclonal, Humanized -- administration & dosage
Antibodies, Monoclonal, Humanized -- economics
Asthma -- drug therapy
Asthma -- immunology
Eosinophilia -- drug therapy
Interleukin-5 -- immunology
Cost-Benefit Analysis
Glucocorticoids -- administration & dosage
Humans
United States
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Chapman, Rick, author
Shore, Karen K., author
Weissberg, Jed, author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, March 14, 2016
- Subject(s):
- Blood Glucose -- drug effects
Diabetes Mellitus, Type 1 -- drug therapy
Diabetes Mellitus, Type 2 -- drug therapy
Hypoglycemia -- prevention & control
Hypoglycemic Agents -- therapeutic use
Insulin, Long-Acting -- administration & dosage
Insulin, Long-Acting -- therapeutic use
Blood Glucose -- metabolism
Cost-Benefit Analysis
Diabetes Mellitus, Type 1 -- blood
Diabetes Mellitus, Type 1 -- complications
Diabetes Mellitus, Type 2 -- blood
Diabetes Mellitus, Type 2 -- complications
Hypoglycemia -- blood
Hypoglycemia -- chemically induced
Hypoglycemic Agents -- administration & dosage
Insulin -- adverse effects
Severity of Illness Index
Humans
United States
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Weissberg, Jed, author
Shore, Karen K., author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, August 19, 2014
- Subject(s):
- Analgesics, Opioid -- therapeutic use
Botulinum Toxins, Type A -- therapeutic use
Emergency Medical Services
Magnetic Field Therapy
Migraine Disorders -- drug therapy
Migraine Disorders -- economics
Migraine Disorders -- prevention & control
Migraine Disorders -- therapy
Transcutaneous Electric Nerve Stimulation
Analgesics, Opioid -- adverse effects
Analgesics, Opioid -- economics
Chronic Disease
Cost-Benefit Analysis
Disease Management
Insurance Coverage
Migraine Disorders -- epidemiology
Migraine with Aura -- therapy
Randomized Controlled Trials as Topic
Technology Assessment, Biomedical
Treatment Outcome
Humans
California
United States
- Author(s):
- Ollendorf, Daniel A., author
Shore, Karen K., author
Cameron, Chris, author
Weissberg, Jed, author
Loos, Anne M., author
Synnott, Patricia, author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, August 10, 2015
- Subject(s):
- Disease Management
Obesity -- therapy
Anti-Obesity Agents
Bariatric Surgery -- economics
Bariatric Surgery -- statistics & numerical data
Body Mass Index
Comparative Effectiveness Research
Cost-Benefit Analysis
Insurance Coverage
Obesity -- complications
Obesity -- etiology
Obesity -- prevention & control
Practice Guidelines as Topic
Technology Assessment, Biomedical
Weight Loss
Humans
United States
